The Acquirer's Multiple®

Seasoned investors are increasingly leaning into a setup where uncertainty coexists with what they see as unusually attractive valuations. During his recent interview with Bloomberg, Bill Ackman captured that dynamic directly, noting that “we think it’s a very good time to put the capital to work,...

In the high-stakes environment of global markets, few figures command as much respect as Paul Tudor Jones. While often categorized as a legendary trader, his reflections reveal a deep appreciation for the contrasting philosophies that drive wealth creation.

In his recent interview with the Inves...

This week’s Acquirer’s Multiple® Large-Cap screen remains concentrated in specialty finance, energy producers, housing-related cyclicals, and a diverse group of mature, cash-generative businesses where operating performance continues to outpace cautious market sentiment.

Markets remain heavily skewed toward growth narratives—particularly technology,...

Jeremy Grantham’s long career offers a useful reminder that investing is less about elegant theory than repeated encounters with human behavior. Markets change costumes, but greed, fear, and impatience rarely miss an earnings season. His own framework starts with a plain preference for value: “cheap is better than expensive.” That sounds obvious, yet every cycle proves how qu...

According to the most recent reported 13F filings, institutional investors showed selective but constructive buying interest in Quest Diagnostics Inc. (DGX), with activity led by value-focused managers, fundamental stock pickers, and quantitative investors. This accumulation suggests growing confidence in Quest’s resilient diagnostics franchise, stable cash generation, and it...